❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Molecular Cell Biology ❭ Tor Erik Rusten's group ❭ Tweets ❭

Go to rustenlab on Twitter

 
Scroll to top

Home Dept. of Molecular Cell Biology Tor Erik Rusten's group

  • Research projects
  • Group members
  • Former members
  • Publications
  • LINKS
  • Tweets

Recent publications

Kelly MG, Free G, Simaika JP, Warner S, Bruder A, Correa-Bedoya A, de Oliveira Roque F, Eriksen TE, Lento J, Macadam CR, Meissner K, Moretti MS, Penrose D, Stribling J, Poikane S (2025)
The global role of bioassessment in policy delivery and decision-making for inland waters
J Environ Manage, 393, 127099 (in press)
DOI 10.1016/j.jenvman.2025.127099, PubMed 40886466

Norborg H, Aarseth JH, Mannseth J, Henriksen HN, Grytten N, Myhr KM, Wergeland S (2025)
Effect of early highly effective treatment compared to an escalating treatment strategy in multiple sclerosis
Mult Scler Relat Disord, 103, 106702 (in press)
DOI 10.1016/j.msard.2025.106702, PubMed 40886413

Lamy A, Sandhu RK, Tong W, McIntyre WF, Lopes RD, Granger CB, Wright DJ, Nielsen JC, Kutyifa V, Erath JW, Alings M, Birnie DH, Atar D, Hohnloser SH, Linde C, Kautzner J, Benezet-Mazuecos J, Camm AJ, Sticherling C, Gold MR, Larroudé CE, Healey JS (2025)
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trial
Europace (in press)
DOI 10.1093/europace/euaf195, PubMed 40886070

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)